RAJIV A PATEL
CIK 1275110 · last filed 2021-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$147.09M
Companies
6
Total Filings
28
Lifetime Open-Market Net
-$932.78M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Playa Hotels & Resorts N.V. (PLYA) Delisted | 8,767,583 | $13.48 | $118.19M | -$365.59M | 1 | 2021-05-21 | |
| Nexvet Biopharma plc (NVET) Delisted | Director | 2,662,276 | — | — | $0 | 17 | 2017-07-05 |
| HPP | 10%+ Owner | 1,449,879 | $14.87 | $21.56M | -$537.52M | 2 | 2014-03-27 |
| EPL OIL & GAS, INC. (EPL) Delisted | 10%+ Owner | 4,449,629 | — | — | -$38.40M | 1 | 2010-03-25 |
| CLUB | 10%+ Owner | 5,143,904 | $24.40 | $125.53M | -$5.53M | 3 | 2010-02-19 |
| KNOLOGY INC (KNOL) Delisted | 10%+ Owner | 4,664,250 | — | — | $14.26M | 3 | 2007-11-14 |
Recent Filings · Page 2 of 3
28 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-02-26 | Nexvet Biopharma plc (NVET) Delisted | — | — | $0 | EDGAR |
| 2016-01-04 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +500 | $62 | EDGAR |
| 2015-10-02 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +500 | $62 | EDGAR |
| 2015-09-11 | Nexvet Biopharma plc (NVET) Delisted | — | — | $0 | EDGAR |
| 2015-09-08 | Nexvet Biopharma plc (NVET) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-07-01 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +1,400 | $175 | EDGAR |
| 2015-06-24 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +980 | $122 | EDGAR |
| 2015-05-22 | Nexvet Biopharma plc (NVET) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-20 | Nexvet Biopharma plc (NVET) Delisted | Grant (A) | +7,380 | $0 | EDGAR |
| 2014-03-27 | HPP | Sell (S) | −35,118,450 | -$777.52M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.